Neuromuscular diseases in intensive care

Main Article Content

Yahya Lahrichi*
Ghita Mninou
Ali Derkaoui
Ibrahim Bechri
Abdelkrim Shimi
Mohammed Khatouf

Abstract

Guillain-Barre syndrome and myasthenia gravis are common in the Intensive Care Unit (ICU) and are not always easy to diagnose in the emergency department. The short-term risk is the occurrence of respiratory muscle paralysis, which must be monitored by repeated measurement of vital capacity, and the existence of respiratory impairment requires transfer to intensive care. Apart from specific therapeutic options (plasma exchange, intravenous immunoglobulins and anticholinesterase agents), management is mainly symptomatic. Our work is a retrospective study, concerning 23 cases of neuromuscular diseases in the ICU from a period from 2018 to 2022. The various epidemiological, clinical, paraclinical, therapeutic, and evolutionary data were collected from the files of the Intensive Care Department A1 of the Hassan II University Hospital of Fez for the study. Osteomas of the paranasal sinuses are benign, often asymptomatic, tumors that progress very slowly. Endocranial development of an osteoma can breach the dura mata, allowing air to enter the cranium producing pneumocephalia which leads to severe neurological deficiencies. Pneumocephalia is an exceptional complication of osteoma.

Downloads

Download data is not yet available.

Article Details

Lahrichi, Y., Mninou, G., Derkaoui, A., Bechri, I., Shimi, A., & Khatouf, M. (2023). Neuromuscular diseases in intensive care. Global Journal of Medical and Clinical Case Reports, 10(3), 019–021. https://doi.org/10.17352/2455-5282.000172
Case Reports

Copyright (c) 2023 Lahrichi Y, et al.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Licensing and protecting the author rights is the central aim and core of the publishing business. Peertechz dedicates itself in making it easier for people to share and build upon the work of others while maintaining consistency with the rules of copyright. Peertechz licensing terms are formulated to facilitate reuse of the manuscripts published in journals to take maximum advantage of Open Access publication and for the purpose of disseminating knowledge.

We support 'libre' open access, which defines Open Access in true terms as free of charge online access along with usage rights. The usage rights are granted through the use of specific Creative Commons license.

Peertechz accomplice with- [CC BY 4.0]

Explanation

'CC' stands for Creative Commons license. 'BY' symbolizes that users have provided attribution to the creator that the published manuscripts can be used or shared. This license allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author.

Please take in notification that Creative Commons user licenses are non-revocable. We recommend authors to check if their funding body requires a specific license.

With this license, the authors are allowed that after publishing with Peertechz, they can share their research by posting a free draft copy of their article to any repository or website.
'CC BY' license observance:

License Name

Permission to read and download

Permission to display in a repository

Permission to translate

Commercial uses of manuscript

CC BY 4.0

Yes

Yes

Yes

Yes

The authors please note that Creative Commons license is focused on making creative works available for discovery and reuse. Creative Commons licenses provide an alternative to standard copyrights, allowing authors to specify ways that their works can be used without having to grant permission for each individual request. Others who want to reserve all of their rights under copyright law should not use CC licenses.

Abgrall G. Epidemiology of intensive care neuromyopathy in Fort-de-France: incidence, facilitating factors and external validation of a predictive score: the NERVIF study. Human Medicine and Pathology. 2015.

Garric JR. Guillain-Barré and Strohl syndrome in intensive care. Life Sciences. 2014.

Svahn J, Chenevier F, Bouhour F, Vial C. Myasthenias and myasthenic syndromes. EMC Neurologie. 2018.

Benchekroun EM. Myasthenia gravis: Experience of the neurology department of the Moulay Ismaël military hospital in Meknes. Med Thesis: Sidi Mohammed Ben Abdellah University. 2016.

Ritzenthaler T, Sharshar T, Orlikowski D. Guillain-Barré syndrome. EMC - Anesthesia-Reanimation. 2014; 11.

Balili K. Management of Guillain-Barré syndrome: comparison between Intravenous Immunoglobulins and Plasmapheresis. These FMPM. 2020.

Grapperon A, Attarian S. Guillain-Barré syndrome. EMC - Neurol. 2016.

Bouche P, Léger JM, Vallat JM. Peripheral neuropathies. Polyneuropathies and multiple mononeuropathies. Rueil-Malmaison. Doin. 2004; 2.

Doets AY, Verboon C, van den Berg B, Harbo T, Cornblath DR, Willison HJ, Islam Z, Attarian S, Barroso FA, Bateman K, Benedetti L, van den Bergh P, Casasnovas C, Cavaletti G, Chavada G, Claeys KG, Dardiotis E, Davidson A, van Doorn PA, Feasby TE, Galassi G, Gorson KC, Hartung HP, Hsieh ST, Hughes RAC, Illa I, Islam B, Kusunoki S, Kuwabara S, Lehmann HC, Miller JAL, Mohammad QD, Monges S, Nobile Orazio E, Pardo J, Pereon Y, Rinaldi S, Querol L, Reddel SW, Reisin RC, Shahrizaila N, Sindrup SH, Waqar W, Jacobs BC; IGOS Consortium. Regional variation of Guillain-Barré syndrome. Brain. 2018 Oct 1;141(10):2866-2877. doi: 10.1093/brain/awy232. PMID: 30247567.